Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor
Clinical trial NCT04867837 · TERMINATED
Trial details
- NCT number
- NCT04867837
- Sponsor
- Octapharma
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2026-01-13
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.